How our brains blend cues from multiple senses to estimate our speed and position in space depends on where we are and how fast we seem to be moving.
Stanford researchers identify a new protein that can fully substitute for one of the key "Yamanaka factors" to reprogram adult stem cells.
Continuously monitoring blood sugar levels turns up new evidence to suggest that more people have sharp increases in their blood sugar than expected.
Video interviews from Stanford's Big Data in Precision Health conference explore topics from artificial intelligence in radiology to clinical informatics.
What if you could stitch together single cells any way you wanted to? Potential medical and even industrial applications abound.
Found in about half of all bacterial species, the cell membrane that surrounds the cell wall may be more critical for survival than previously thought.
Direct-to-consumer raw genetic data can be inaccurate, resulting in harm to patients and unnecessary costs to the health care system, new research suggests.
Today, diagnosing rare genetic diseases requires slow, educated guesswork, but a team of Stanford experts is automating the process.
A former Stanford biodesign innovation fellow describes how he and colleagues came to develop an inexpensive and simple tool to diagnose arrhythmias.
A small magnetic wire that attracts nanoparticles engineered to stick to tumor cells may stand to detect cancer earlier.
John Ioannidis recommends a change to the standards of nutrition research studies, suggesting that, as they stand, the results are fairly unreliable.
Data analyst Jonathan Altamirano discusses living in Nicaragua as a child and how that inspired his current health research at Stanford.
In an interview, Stanford bioengineer Michael Fischbach discussed the growing knowledge of the bacteria in our bodies and what that means for the future of medicine.
Testing the side effects of every drug combination is impractical, but Stanford researchers think they have a better way: artificial intelligence.
Targeted screening can cut hepatitis B related deaths in the U.S. by half - and save money.
A new study shows that the process of turning a group of blood vessel cells into an artery actually requires that they stop growing.